- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Stryker Corporation (SYK)
Stryker Corporation stock price live, this page displays NYSE SYK stock exchange data. View the SYK premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Stryker Corporation real time stock price chart below.
What Is the Stryker Corporation Stock Price Today?
The Stryker Corporation stock price today is 376.37.
What Is the Stock Symbol for Stryker Corporation?
The stock symbol for Stryker Corporation is ""SYK.""
What Stock Exchange Does Stryker Corporation Trade On?
Stryker Corporation is listed and trades on the NYSE stock exchange.
Is Stryker Corporation a Good Stock to Buy?
Determining whether Stryker Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SYK quote. (ISIN: US8636671013)
What Is the Stryker Corporation Stock Price Today?
The Stryker Corporation stock price today is 376.37.
What Is the Stock Symbol for Stryker Corporation?
The stock symbol for Stryker Corporation is ""SYK.""
What Stock Exchange Does Stryker Corporation Trade On?
Stryker Corporation is listed and trades on the NYSE stock exchange.
Is Stryker Corporation a Good Stock to Buy?
Determining whether Stryker Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SYK quote. (ISIN: US8636671013)
376.37
+1.43(+0.38%)
Closed·
After Hours
377.49+1.12(+0.30%)
·
Fair Value
An estimate of a Stryker's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
373.72
381.34
52 wk Range
320.78
406.19
SYK Scorecard
Full Analysis
Has raised its dividend for 15 consecutive years
SYK is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Stryker's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
373.72381.34
52 wk Range
320.78406.19
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.89%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.89%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SYK Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Stryker's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
432.27
Upside
+14.85%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
16 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Stryker Corporation Company Profile
Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke, cranial, and maxillofacial and chest wall devices, as well as dural substitutes and sealants; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries; thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Stryker Corporation SWOT Analysis
Strategic Expansion | Stryker's acquisition of Inari Medical for $4.9 billion positions the company for growth in the rapidly expanding peripheral vascular market |
Robotic Revolution | Explore Stryker's market leadership in surgical robotics, with record adoption of its Mako system driving significant market share gains in orthopedics |
Financial Fortitude | Delve into Stryker's robust financial performance, with 10.76% revenue growth and a "GREAT" financial health score, despite challenges like tariff headwinds |
Analyst Optimism | Discover why analysts are bullish on Stryker, with price targets ranging from $420 to $450, reflecting confidence in the company's growth strategy |
Stryker Corporation Earnings Call Summary for Q2/2025
- Stryker Q2 2025 EPS of $3.13 beat $3.07 forecast; revenue of $6.02B exceeded $5.94B estimate; organic sales grew 10.2%
- Full-year 2025 guidance raised: organic net sales growth now 9.5-10%, adjusted EPS $13.4-$13.6; strong growth in robotic procedures expected
- Stock declined 1.92% to $400.41 despite earnings beat; slight recovery in aftermarket trading to $401.95
- CEO highlighted leadership in orthopedic robotics; plans to expand product offerings with Mako Spine and Shoulder systems
- Challenges include supply chain disruptions, market saturation, and regulatory changes in international markets
Last Updated: 01/08/2025, 01:08
Read Full TranscriptCompare SYK to Peers and Sector
Metrics to compare | SYK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSYKPeersSector | |
|---|---|---|---|---|
P/E Ratio | 49.1x | 13.7x | −0.5x | |
PEG Ratio | −3.11 | 0.41 | 0.00 | |
Price/Book | 6.8x | 2.1x | 2.6x | |
Price / LTM Sales | 6.0x | 1.5x | 3.3x | |
Upside (Analyst Target) | 16.8% | 92.7% | 43.5% | |
Fair Value Upside | Unlock | 20.9% | 6.9% | Unlock |
Analyst Ratings
21 Buy
9 Hold
1 Sell
Ratings:
31 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 432.27
(+14.85% Upside)
Earnings
Latest Release
Jul 31, 2025
EPS / Forecast
3.13 / 3.07
Revenue / Forecast
6.02B / 5.94B
People Also Watch
FAQ
What Stock Exchange Does Stryker Trade On?
Stryker is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Stryker?
The stock symbol for Stryker is "SYK."
What Is the Stryker Market Cap?
As of today, Stryker market cap is 143.66B.
What Is Stryker's Earnings Per Share (TTM)?
The Stryker EPS (TTM) is 7.65.
When Is the Next Stryker Earnings Date?
Stryker will release its next earnings report on 29 Oct 2025.
From a Technical Analysis Perspective, Is SYK a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Stryker Stock Split?
Stryker has split 9 times.
How Many Employees Does Stryker Have?
Stryker has 53000 employees.
What is the current trading status of Stryker (SYK)?
As of 07 Aug 2025, Stryker (SYK) is trading at a price of 376.37, with a previous close of 374.94. The stock has fluctuated within a day range of 373.72 to 381.34, while its 52-week range spans from 320.78 to 406.19.
What Is Stryker (SYK) Price Target According to Analysts?
The average 12-month price target for Stryker is USD432.27037, with a high estimate of USD465 and a low estimate of USD316. 21 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +14.85% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.